MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.amjmed.2023.10.024

Медицинская библиотека · The American journal of medicine · 2023

Body Mass Index and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in the ISCHEMIA-CKD Trial.

Mathew Roy O, Kretov Evgeny I, Huang Zhen, Jones Philip G, Sidhu Mandeep S, O'Brien Sean M, Prokhorikhin Aleksei A, Rangaswami Janani, Newman Jonathan, Stone Gregg W, Fleg Jerome L, Spertus John A, Maron David J, Hochman Judith S, Bangalore Sripal, ISCHEMIA-CKD Research Group

СтатьяПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

OBJECTIVE

This study aimed to assess whether an obesity paradox (lower event rates with higher body mass index [BMI]) exists in participants with advanced chronic kidney disease (CKD) and chronic coronary disease in the International Study of Comparative Health Effectiveness of Medical and Invasive Approaches (ISCHEMIA)-CKD, and whether BMI modified the effect of initial treatment strategy.

METHODS

Baseline BMI was analyzed as both a continuous and categorical variable (< 25, ≥ 25 to < 30, ≥ 30 kg/m2). Associations between BMI and the primary outcome of all-cause death or myocardial infarction (D/MI), and all-cause death, cardiovascular death, and MI individually were estimated. Associations with health status were also evaluated using the Seattle Angina Questionnaire-7, the Rose Dyspnea Scale, and the EuroQol-5D Visual Analog Scale.

RESULTS

Body mass index ≥ 30 kg/m2 vs < 25 kg/m2 demonstrated increased risk for MI (hazard ratio [HR] [95% confidence interval] = 1.81 [1.12-2.92]) and for D/MI (HR 1.45 [1.06-1.96]) with a HR for MI of 1.22 (1.05-1.40) per 5 kg/m2 increase in BMI in unadjusted analysis. In multivariate analyses, a BMI ≥ 30 kg/m2 was marginally associated with D/MI (HR 1.43 [1.00-2.04]) and greater dyspnea throughout follow-up (P < .05 at all time points). Heterogeneity of treatment effect between baseline BMI was not evident for any outcome.

CONCLUSIONS

In the ISCHEMIA-CKD trial, an obesity paradox was not detected. Higher BMI was associated with worse dyspnea, and a trend toward increased D/MI and MI risk. Larger studies to validate these findings are warranted.

Для цитирования: Mathew Roy O, Kretov Evgeny I, Huang Zhen, Jones Philip G, Sidhu Mandeep S, O'Brien Sean M, Prokhorikhin Aleksei A, Rangaswami Janani, Newman Jonathan, Stone Gregg W, Fleg Jerome L, Spertus John A, Maron David J, Hochman Judith S, Bangalore Sripal, ISCHEMIA-CKD Research Group. Body Mass Index and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in the ISCHEMIA-CKD Trial.. The American journal of medicine. 2023. DOI: 10.1016/j.amjmed.2023.10.024.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.